Compare Edwards Lifesciences Corporation Common Stock (EW) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs JPMorgan Chase & Co — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while JPMorgan Chase & Co trades at $331.82 (market cap $876.09B). The key difference: JPMorgan Chase & Co is far larger — about 17.7× Edwards Lifesciences Corporation Common Stock's market cap, and JPMorgan Chase & Co pays a 2% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | JPM | |
|---|---|---|
Market Cap | $49.44B | $876.09B |
Volume | 3,508,027 | 6,651,143 |
Sector | Health | Financials |
52-Week High | $95.18 | $365.18 |
52-Week Low | $72.65 | $282.84 |
Enterprise Value | $45.90B | $1.81T |
Typical Hold Time | — | 127 Days |
Dividend Yield | — | 2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JPMorgan Chase trades at $331.42, up 0.04% with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 EPS of $7.59, beating expectations by 36%, with revenue reaching $181.85B in 2025. Analyst consensus remains positive with a $373.18 price target and 52% buy ratings, though technical indicators show selling pressure with RSI levels suggesting potential oversold conditions near key support at $323.
JPMorgan demonstrates robust profitability with 18.43% ROE and reasonable valuation at 14.12 P/E, but faces risks from geopolitical tensions and cybersecurity threats. The stock offers upside to analyst targets with strong institutional support, though negative cash flow trends and bearish technical momentum warrant caution amid macroeconomic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
